Effect of Probiotic's Consumption on Several Markers in Perforated Appendix Patients with Diffuse Peritonitis
NCT ID: NCT06856434
Last Updated: 2025-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
EARLY_PHASE1
50 participants
INTERVENTIONAL
2025-06-01
2026-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Probiotics in Improving Quality of Life in Women With Functional Constipation
NCT03829358
Efficacy and Safety of Probiotic Products for Digestive Health
NCT06385639
The Effect of Enteral Nutrition Supplemented With Prebiotics on Colonic Microbiota in the Critically Ill Patients
NCT02144168
Tolerability and Risk of Adverse Events With a Probiotic Supplement
NCT03728868
Comparison of Probiotic Effects on the Outcomes of Patients After Colorectal Cancer Surgery
NCT07144475
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Probiotic Group
Patient with perforated appendicitis who received an intervention
Lactobacillus plantarum sp Probiotic
Once daily consumption
Placebo Group
Patients with perforated appendicitis who did not receive an intervention
Placebo Group
Group who received a placebo intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactobacillus plantarum sp Probiotic
Once daily consumption
Placebo Group
Group who received a placebo intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing laparotomic appendectomy.
* Patients aged 18 years or older.
Exclusion Criteria
* Patients who underwent laparotomy combined with surgery on other parts of the body.
* Patients with a history of cancer.
* Patients with pre-existing comorbidities (uncontrolled diabetes mellitus, congestive heart failure, end-stage renal disease \[ESRD\], human immunodeficiency virus \[HIV\], and systemic lupus erythematosus \[SLE\]).
* Patients with multiple organ dysfunction syndrome (MODS).
* Patients with prior consumption of probiotics.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitas Padjadjaran
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ricarhdo Valentino Hanafi, MD
Principal Investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Guan L, Liu Z, Pan G, Zhang B, Wu Y, Gan T, Ouyang G. The global, regional, and national burden of appendicitis in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. BMC Gastroenterol. 2023 Feb 22;23(1):44. doi: 10.1186/s12876-023-02678-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SURG-202407.01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.